Mostrando 1,341 - 1,360 Resultados de 1,481 Para Buscar '"pneumococcal disease"', tiempo de consulta: 0.21s Limitar resultados
  1. 1341
    por Castiglia, Paolo
    Publicado 2014
    “…The global burden of pneumococcal diseases is high, with young children and adults ≥50 years of age at highest risk of infection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Recommendations for Pneumococcal Immunization Outside Routine Childhood Immunization Programs in Western Europe
  2. 1342
    “…The 7-valent pneumococcal protein conjugate vaccine (PCV7) has been shown to be highly efficacious against invasive pneumococcal diseases and effective against pneumonia and in reducing otitis media. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines
  3. 1343
    “…These vaccines have been extensively studied, are currently in human trial phase 1/2, and seem to be the best treatment choice for pneumococcal diseases, especially for developing countries.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Next-Generation Whole-Cell Pneumococcal Vaccine
  4. 1344
    por Ordóñez, Jaime E, Orozco, John J
    Publicado 2014
    “…BACKGROUND: Nowadays, there are two vaccination strategies in Colombia to prevent pneumococcal diseases in people over 50 years. Our aim is to estimate cost-effectiveness of pneumococcal conjugate vaccine 13-valent (PCV13) versus pneumococcal polysaccharide vaccine 23-valent (PPSV23) to prevent pneumococcal diseases and their related mortality in people over 50 years old in Colombia. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
  5. 1345
    “…Pneumococcal diseases are associated with a significant clinical and economic burden. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Overall effectiveness of pneumococcal conjugate vaccines: An economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy
  6. 1346
    “…Similar to the global scenario, pneumococcal diseases are a significant health concern in India. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical practice guidelines 2019: Indian consensus-based recommendations on pneumococcal vaccination for adults
  7. 1347
    “…The primary outcome was invasive pneumococcal diseases (IPDs), and the secondary outcomes were medical utilization. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effectiveness of 23-valent pneumococcal polysaccharide vaccine on diabetic elderly
  8. 1348
    “…Because the incidence of pneumococcal diseases is likely to increase with the aging society, we should determine an optimal strategy for pneumococcal vaccination. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Theory and strategy for Pneumococcal vaccines in the elderly
  9. 1349
    “…Infections by Streptococcus pneumoniae can cause serious pneumococcal diseases and other medical complications among patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Characterization of High Molecular Weight Pneumococcal Conjugate by SEC-MALS and AF4-MALS
  10. 1350
    “…Serotype 3 Streptococcus pneumoniae is associated with major invasive pneumococcal diseases in humans. We report the circularized 2.0-Mbp complete genome sequence of invasive serotype 3 S. pneumoniae strain B1900, untypeable by multilocus sequence typing (MLST). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Complete Genome Sequence of Invasive MLST-Untypeable Serotype 3 xpt-Deficient Streptococcus pneumoniae Strain B1900, Isolated from the Brain of an Infant Rhesus Monkey (Macaca mulatta) That Died of Meningitis
  11. 1351
    “…INTRODUCTION: Streptococcus pneumoniae is a worldwide occurring pathogen Nasopharyngeal carriage of Streptococcus pneumoniae precedes pneumonia and other pneumococcal diseases in the community. Little is known about S. pneumoniae carriage in Indonesia, complicating strategies to control pneumococcal diseases. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Nasopharyngeal Carriage of Streptococcus pneumonia in Pneumonia-Prone Age Groups in Semarang, Java Island, Indonesia
  12. 1352
    por Potera, C
    Publicado 1999
    “…Pneumococcal diseases, caused by the bacterium Streptococcus pneumoniae, include pneumonia and otitis media, which accounts for some 12 million doctor visits per year in the United States alone. …”
    Enlace del recurso
    Enlace del recurso
    Texto
    Look, Ma! No pneumococcus!
  13. 1353
    “…Background: Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) can cause invasive pneumococcal diseases (IPD), pneumonia, and acute otitis media (AOM). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea
  14. 1354
    “…Pneumonia with bacteremia accounts for the majority (70%) of cases of invasive pneumococcal diseases. Laboratory characterization of pneumococci is routinely done by sensitivity to optochin. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Atypical Pneumococcal Isolate from Blood
  15. 1355
    por Krishnamurthy, A., Palombo, E.
    Publicado 2016
    “…The increased incidence of pneumococcal diseases in both developed and developing countries is alarmingly high, affecting infants and aged adult populations. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Current therapeutics and prophylactic approaches to treat pneumonia
  16. 1356
    por Saleri, Nuccia, Ryan, Edward T.
    Publicado 2019
    “…All travelers should be up to date on any indicated vaccines based on age and medical condition that prevent RTIs, including influenza, measles, pneumococcal diseases, Haemophilus influenzae b, Neisseria meningitidis, diphtheria, and pertussis.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Respiratory Infections
  17. 1357
    “…OBJECTIVE: This study was conducted to investigate the cost-effectiveness of implementing PCV20 in a reimbursement scheme for Norwegian adults aged 18–99 years at risk of pneumococcal diseases and those aged 65 years and older at low risk compared to PPV23. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
  18. 1358
    “…WHAT IS ALREADY KNOWN ON THIS TOPIC? Pneumococcal diseases (PDs) are serious threats to child health. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Factors Associated with PCV13 Vaccine Hesitancy in Parents under an Innovative Immunization Strategy: a Cross-Sectional Study — Weifang City, Shandong Province, China, 2021
  19. 1359
    “…Pneumococcal conjugate vaccines have been shown in children to be able to prevent invasive and mucosal pneumococcal diseases. It should be realized that the serotype composition of current pneumococcal conjugate vaccines is not tailored for the elderly, and that replacement disease can occur. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly
  20. 1360
    por Kim, Sun-Young, Lee, Gene, Goldie, Sue J
    Publicado 2010
    “…CONCLUSIONS: Based on the information available now, infant PCV vaccination would be expected to reduce pneumococcal diseases caused by S. pneumoniae in The Gambia. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Economic evaluation of pneumococcal conjugate vaccination in The Gambia
Herramientas de búsqueda: RSS